Repligen Corp. (RGEN)
172.54
-1.34
(-0.77%)
USD |
NASDAQ |
Oct 12, 16:00
172.54
0.00 (0.00%)
After-Hours: 16:52
Repligen Free Cash Flow (Quarterly) : 26.70M for June 30, 2026
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 26.70M |
| March 31, 2026 | 23.35M |
| December 31, 2025 | 17.40M |
| September 30, 2025 | 42.71M |
| June 30, 2025 | 21.00M |
| March 31, 2025 | 10.58M |
| December 31, 2024 | 29.18M |
| September 30, 2024 | 42.18M |
| June 30, 2024 | 34.79M |
| March 31, 2024 | 36.34M |
| December 31, 2023 | 17.95M |
| September 30, 2023 | 30.18M |
| June 30, 2023 | 25.08M |
| March 31, 2023 | 1.721M |
| December 31, 2022 | 40.49M |
| September 30, 2022 | -16.14M |
| June 30, 2022 | 19.50M |
| March 31, 2022 | -5.118M |
| December 31, 2021 | 16.26M |
| September 30, 2021 | 10.84M |
| June 30, 2021 | 20.45M |
| March 31, 2021 | 0.194M |
| December 31, 2020 | 3.179M |
| September 30, 2020 | 16.35M |
| June 30, 2020 | 12.26M |
| Date | Value |
|---|---|
| March 31, 2020 | 4.493M |
| December 31, 2019 | 10.56M |
| September 30, 2019 | 15.05M |
| June 30, 2019 | 12.49M |
| March 31, 2019 | 5.96M |
| December 31, 2018 | 1.353M |
| September 30, 2018 | 15.51M |
| June 30, 2018 | 3.115M |
| March 31, 2018 | 0.008M |
| December 31, 2017 | 13.45M |
| September 30, 2017 | -2.738M |
| June 30, 2017 | 1.433M |
| March 31, 2017 | -0.148M |
| December 31, 2016 | 1.091M |
| September 30, 2016 | -3.242M |
| June 30, 2016 | 9.589M |
| March 31, 2016 | -4.242M |
| December 31, 2015 | 2.779M |
| September 30, 2015 | 6.270M |
| June 30, 2015 | 6.952M |
| March 31, 2015 | -3.576M |
| December 31, 2014 | -0.885M |
| September 30, 2014 | 4.588M |
| June 30, 2014 | 1.694M |
| March 31, 2014 | 7.402M |
Free Cash Flow Definition
Free Cash Flow is the cash a company has left after paying for its day-to-day operations and investing in its physical assets, such as buildings, equipment and technology. The company can use that cash however it chooses: paying dividends, buying back shares, paying down debt, making acquisitions or keeping it for future growth.
Free Cash Flow (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow (Quarterly) Benchmarks
| BioLife Solutions, Inc. | 5.185M |
| Anika Therapeutics, Inc. | -2.133M |
| Danaher Corp. | 1.265B |
| Precigen, Inc. | -18.20M |
| Liquidia Corp. | 69.01M |